SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-500121
Filing Date
2016-03-10
Accepted
2016-03-10 16:11:07
Documents
3
Period of Report
2016-03-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d159286d8k.htm 8-K 15653
2 EX-4.1 d159286dex41.htm EX-4.1 6717
3 EX-4.2 d159286dex42.htm EX-4.2 40806
  Complete submission text file 0001193125-16-500121.txt   64377
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36281 | Film No.: 161497908
SIC: 2834 Pharmaceutical Preparations